Methyl B12 3000 mcg Berry Flavor
Goals
$16.99 $0.33 per serving
Product analysis
Methyl B12 3000 mcg Berry Flavor supplies B12 and folate to support normal blood-cell production when intake falls short. Its high B12 amount does not establish extra energy or improved work performance once nutritional needs are met.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
The B12 and vitamin C forms are named, but their relative quality remains uncertain. The undisclosed folate form also limits comparison with other formulas.
Ingredient Transparency88
All three ingredient amounts are disclosed, making the serving easy to check. The folate form is missing, leaving part of the formula less clear.
Value For Money40
Value for money remains uncertain. The ingredient price comparisons are incomplete, so a clear price advantage cannot be established.
Customer Satisfaction76
Customer ratings are generally positive across several hundred reviews. The feedback describes satisfaction without proving energy, hair or concentration benefits.
Product Focus74
B12 and folate provide the main nutritional purpose through normal blood-cell production and metabolism. Benefits for fatigue or concentration are most plausible when nutrient status is low.
- Format
Lozenge - Container
- 50 Liquid(s)
- Per serving
- $0.33
- Also available
Methyl B12 3000 mcg Berry Flavor$21.47- Customer rating
- 4.6 · 652 ratings
Goals
Impact
Highest effect
Folate · 667 mcg DFEVitamin B12 · 3000 mcgVitamin C · 50 mg
Impact
High effect
Vitamin C · 50 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin C (Ascorbic Acid) | 50 mg | |
Folate | 667 mcg DFE | |
Vitamin B12 (Methylcobalamin) | 3000 mcg |
Vitamin B12 (Methylcobalamin) · 3000 mcg OverallScore96
Each serving provides 3000 mcg of B12, with a low cost for the amount of B12. Methylcobalamin is a bioactive form.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The B12 is methylcobalamin.
Bioactive B12 Form Selection
Methylcobalamin is the listed B12 form.
Dose, Safety & Label Transparency100
The label states 3000 mcg of B12 per serving and names methylcobalamin.
Therapeutic Dosage Level
Each serving supplies 3000 mcg of B12.
Label and Form Transparency
The label states the amount and names methylcobalamin.
Value80
The cost is low for the amount of B12 provided.
Price per 1,000 mcg B12
The cost is low for the amount of B12 provided.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to All-Cause and Cause-Specific Mortality: A National Population-Based Cohort.
- The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.
- Associations of Serum Folate and Homocysteine Concentrations with All-Cause, Cardiovascular Disease, and Cancer Mortality in Men and Women in Korea: the Cardiovascular Disease Association Study.
- The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA.
- Systematic review of adverse health outcomes associated with high serum or red blood cell folate concentrations.
- Oral Vitamin B12 versus Placebo for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Gynecological Cancer Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial.
- A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia.
- Local Injection of Methylcobalamin Combined with Lidocaine for Acute Herpetic Neuralgia.
- The Effect of Vitamin B12 and Folic Acid Supplementation on Serum Homocysteine, Anemia Status and Quality of Life of Patients with Multiple Sclerosis.
- Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
- Scientific Opinion on the substantiation of a health claim related to vitamin C and increasing non haem iron absorption pursuant to Article 14 of Regulation (EC) No 1924/2006.
- Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients.
- Associations of Serum Biomarkers of Fruit and Vegetable Intake With the Risk of Cause-Specific Mortality and All-Cause Mortality: A National Prospective Cohort Study.
- Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.
- Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis.
- Quantitative Analysis of Selected Circulating Hematological Biomarkers, Essential Minerals, Vitamins, and Thyroid Hormones in Females Affected by Hair Loss.
- Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
- Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
- Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.